ASSIST: A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting
Study Details
Study Description
Brief Summary
Cohort study according to national regulatory guidelines: Non-interventional, observational cohort study. Pair-matched comparison with patients chosen from historical series.
To evaluate the clinical and technical success as well as the safety and feasibility of the E-XL aortic stent used in complicated type B aortic dissection in addition to a classic stentgraft in a single procedure.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Thoracic Stentgraft plus E-XL male and female patients with complicated type B aortic dissection involving the infra-diaphragmatic aorta treated with any thoracic stentgraft extended by the E-XL aortic stent |
|
Control group historical control group fulfilling the following criteria: Age +/- 3 years Sex matched Same follow-up period |
Outcome Measures
Primary Outcome Measures
- To evaluate the clinical and technical success as well as the safety and feasibility of the E-XL aortic stent used in complicated type B aortic dissection in addition to a classic thoracic stent-graft in a single procedure. [February 2014]
Eligibility Criteria
Criteria
The clinical records of the patients mus support the following criteria:
-
Age > 18 years
-
Type B dissection with expanding false lumen eligible for endovascular treatment which occured within 90 days prior to implantation
-
The endovascular treatment may be associated with a complementary surgical operation
-
The total diameter of the dissected aortic segment should not surpass 6cm, and have increased between 0.5 and 1cm within 1 month, prior to implantation
-
Visceral arteries involvement, i.e. perfusion of side branches via true or false lumen of type B dissection
-
Aortic kinking < 90°
-
The patient must be available for the appropriate follow-up times for the duration of the study
-
Informed consent from patient or authorized relative
The data of whose patients clinical records confirm one of the following conditions will not be considered in this study:
-
Patients with a contraindication as indicated in the instruction for use
-
Patients with chronic thrombocytopenia or ongoing anticoagulation
-
Patients with renal failure and/or creatinine >2.4mg/dl immediately before the intervention
-
Patients in whom the false lumen is completely thrombosed
-
Patients with ongoing infection
-
Patients with ongoing cancer
-
Patients who are enrolled in a clinical study
-
Aortic landing zone diameter over 40 mm
-
Potentially emboligenic iliac and aortic atheroma lesions
-
Associated pathology with life expectancy of less than 24 months
-
Unstable infectious syndrome
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Klinikum Augsburg | Augsburg | Germany | ||
2 | German Heart Center | Berlin | Germany | 13353 | |
3 | University Hospital | Essen | Germany | 45147 | |
4 | University Hospital | Freiburg | Germany | ||
5 | Hannover Medical School | Hanover | Germany | 30625 | |
6 | University Hospital | Jena | Germany | 07747 | |
7 | St. Franziskus Hospital | Muenster | Germany | 48145 | |
8 | University Hospital Munich Grosshadern | Munich | Germany | ||
9 | University Hospital | Rostock | Germany | ||
10 | Department of Radiologia Toracica e Vascolare | Bologna | Italy | 40138 | |
11 | IRCCS Policlinico San Donato Milano | Milan | Italy | 20097 | |
12 | Krakowski Szpital Specjalistyczny im. Jana Pawła II | Kraków | Poland | 31-202 | |
13 | Samodzielny Publiczny Szpital Kliniczny Nr 1 | Lublin | Poland | 20-081 | |
14 | Thorax Insitute, Hospital Clinic, University of Barcelona | Barcelona | Spain | 08036 | |
15 | Hospital Clinico Universitario de Valladolid | Valladolid | Spain | 47005 |
Sponsors and Collaborators
- JOTEC GmbH
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ASSIST